Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Du bruger tilsyneladende en bredere skærm. Vil du gerne give denne side en bredere visningsoplevelse?

BioPorto - Presentation of strategic plans

Af HC Andersen Capital
BioPorto

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

Meet and ask questions to interim CEO Peter Mørch Eriksen from BioPorto on 22 February at 2.00 PM.

BioPorto - an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI) - will publish its strategic plans.

Disclaimer: HC Andersen Capital receives payment from Bioporto for a DigitalIR/Corporate Visibility and IR advisory agreement./Claus Thestrup 20 February 08.57 AM.

Seneste videoer

Nightingale, Webcast, Half-year financial report 1 July–31 December 2025
05.03.2026, 13.00 Nightingale Health
Solwers, Webcast, Q4'25
05.03.2026, 11.00 Solwers
Orthex, Webcast, Q4'25
05.03.2026, 10.00 Orthex
HCA Morgenbørs 05/03 - Fortsat uro og fokus på danske regnskaber
05.03.2026, 09.38 Scandinavian Tobacco Group
Systemair, Audiocast, Q3'26
05.03.2026, 09.00 Systemair
Vis alle videoer
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.